Allogene Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · South San Francisco, CA
ALLO chart
What traders are saying about $ALLO
Latest postsAllogene Therapeutics, Inc. news
- Allogene Therapeutics to present at major inves...
Pluang ·
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
Yahoo Finance ·
- Form 4 Allogene Therapeutics Inc: Geoffrey M. Parker (CFO) For: 21 October
Investing.com Nigeria ·
- Allogene Therapeutics CFO Geoffrey Parker sells $48,698 in stock
Investing.com ·
- ALLO News | ALLOGENE THERAPEUTICS INC (NASDAQ:ALLO)
ChartMill ·
- Allogene Therapeutics, Inc. Estimates – NASDAQ:ALLO
TradingView ·
- To cover vesting-related taxes, Allogene Therapeutics (ALLO) CFO sells 36,342 shares.
Stock Titan ·
- Form 144 Allogene Therapeutics For: 21 October By Investing.com
Investing.com UK ·
- An officer proposes selling 36,342 Allogene Therapeutics (NASDAQ: ALLO) shares after stock vesting.
Stock Titan ·
- CLLS Stock Heads For 14-Month Low After 40% Rout: Citizens Flags Delayed Cellectis Catalysts After Cancer Pipeline Pivot
stocktwits.com ·
- Allogene Therapeutics (ALLO) Down 11.1% Since Last Earnings Report: Can It Rebound?
Yahoo Finance ·
- Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts
biopharmadive.com ·
Allogene Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $22,000 | $95,000 | $156,000 |
| Net income | -$190.9M | -$257.6M | -$327.3M | -$340.4M |
| Diluted EPS | $-0.87 | $-1.32 | $-2.09 | $-2.38 |
| Total assets (year end) | $415.9M | $548.7M | $642.8M | $821.6M |
| Cash and equivalents (year end) | $51.7M | $75.2M | $83.2M | $61.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Allogene Therapeutics, Inc.
- Ticker
- ALLO (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- Fiscal year end
- December 31
- SEC CIK
- 1737287
Frequently asked questions
What exchange is Allogene Therapeutics, Inc. listed on?
Allogene Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ALLO.
What industry is Allogene Therapeutics, Inc. in?
Allogene Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Allogene Therapeutics, Inc. headquartered?
Allogene Therapeutics, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Allogene Therapeutics, Inc.'s fiscal year end?
Allogene Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Allogene Therapeutics, Inc. report?
Allogene Therapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.